- Tel: 858.663.9055
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Aquaporin 7 Antibody reagents target AQP7, a member of the aquaglyceroporin subfamily. Unlike classical aquaporins that transport only water, AQP7 facilitates the movement of glycerol, water, and small solutes across cell membranes. This dual transport capacity places AQP7 at the intersection of energy metabolism and fluid regulation.
AQP7 is predominantly expressed in adipocytes, where it mediates glycerol efflux during lipolysis. By exporting glycerol, AQP7 helps regulate lipid storage and energy balance, linking it directly to obesity, insulin resistance, and type 2 diabetes. AQP7 is also found in testis, kidney, pancreas, and muscle, suggesting roles in reproduction, renal physiology, and metabolic homeostasis. Because of these diverse functions, the Aquaporin 7 Antibody is a vital tool for investigating metabolic disease and energy regulation. The AQP7 Antibody complements these studies by providing additional reagents for cross-tissue research.
NSJ Bioreagents provides Aquaporin 7 Antibodies validated for immunohistochemistry, western blotting, immunofluorescence, flow cytometry, and ELISA. Each Aquaporin 7 Antibody undergoes rigorous testing to ensure specificity, reproducibility, and compatibility across multiple research applications.
By choosing Aquaporin 7 Antibodies from NSJ Bioreagents, scientists gain reagents optimized for clarity and consistency. Our antibodies provide strong staining in adipose tissue, reproducible detection in lysates, and dependable performance across discovery and translational platforms. Detailed datasheets, validated controls, and optimized protocols further ensure reproducibility in both laboratory and clinical studies.
The Aquaporin 7 Antibody supports broad applications across metabolism, endocrinology, and translational medicine.
Aquaporin 7 Antibodies detect AQP7 in adipocytes.
The Aquaporin 7 Antibody supports studies of glycerol efflux and lipid metabolism.
AQP7 Antibody reagents validate biomarkers for obesity and insulin resistance.
Aquaporin 7 Antibodies clarify roles in type 2 diabetes and metabolic syndrome.
The Aquaporin 7 Antibody supports studies of pancreatic islet physiology.
AQP7 Antibody reagents contribute to translational diabetes research.
Aquaporin 7 Antibodies identify expression in testis and sperm.
The Aquaporin 7 Antibody supports studies of fertility and reproductive physiology.
AQP7 Antibody reagents provide biomarkers for gamete function.
Aquaporin 7 Antibodies detect expression in renal proximal tubules.
The Aquaporin 7 Antibody supports studies of fluid and solute balance.
AQP7 Antibody reagents validate nephrology biomarkers.
Aquaporin 7 Antibodies highlight roles in skeletal and cardiac muscle.
The Aquaporin 7 Antibody supports studies of energy balance and metabolic adaptation.
AQP7 Antibody reagents clarify cross-talk between tissues in systemic metabolism.
Aquaporin 7 Antibodies are applied in biomarker-driven studies of obesity and diabetes.
The Aquaporin 7 Antibody supports diagnostics in metabolic disorders.
AQP7 Antibody reagents ensure reproducibility across translational pipelines.
AQP7 plays a central role in glycerol transport and energy homeostasis. The Aquaporin 7 Antibody provides validated tools for studying adipose biology, diabetes, and metabolic regulation, while the AQP7 Antibody expands these applications across translational research.
In adipose tissue, Aquaporin 7 Antibodies clarify how glycerol efflux links lipolysis to systemic energy balance. In diabetes research, the Aquaporin 7 Antibody highlights AQP7’s role in insulin resistance and glucose metabolism. In reproductive biology, AQP7 Antibody reagents uncover its contributions to fertility.
Clinically, AQP7 is emerging as a biomarker for obesity, type 2 diabetes, and metabolic syndrome. Reliable Aquaporin 7 Antibodies ensure reproducibility, bridging fundamental metabolism research with clinical applications.
AQP7 is an aquaglyceroporin that integrates lipid metabolism, energy balance, and fluid regulation across multiple organ systems. The Aquaporin 7 Antibody provides validated reagents for studies in adipose tissue, pancreas, kidney, and muscle, while the AQP7 Antibody expands applications in translational and clinical research. By ensuring specificity, reproducibility, and assay versatility, these antibodies remain indispensable for advancing metabolic biology and improving outcomes in obesity and diabetes care.